Skip to content
Medx

Tag: Ezh2 inhibitor

Explore our medication guides and pharmacology articles within this category.

What is Mevrometostat?: An In-Depth Look at a Novel Cancer Therapy

•
4 min read
In early 2025, clinical trial data showed that Mevrometostat combined with enzalutamide reduced the risk of disease progression or death by 49% in some prostate cancer patients. **What is Mevrometostat?** It is an investigational EZH2 inhibitor being developed by Pfizer for advanced prostate cancer.

What is Tazverik (tazemetostat) and How Does It Work?

•
4 min read
Over 90% of epithelioid sarcomas feature a loss of the INI1 protein, a key trigger for the cancerous activity that Tazverik is designed to inhibit. So, **what is Tazverik?** It's a targeted oral cancer medication, not a traditional chemotherapy.